Your browser is no longer supported. Please, upgrade your browser.
TECH Bio-Techne Corporation daily Stock Chart
TECH [NASD]
Bio-Techne Corporation
Index- P/E61.36 EPS (ttm)2.46 Insider Own0.40% Shs Outstand38.89M Perf Week-3.23%
Market Cap5.88B Forward P/E29.56 EPS next Y5.12 Insider Trans-11.39% Shs Float37.62M Perf Month-6.66%
Income94.50M PEG5.93 EPS next Q0.98 Inst Own96.60% Short Float1.99% Perf Quarter-24.34%
Sales661.40M P/S8.89 EPS this Y20.40% Inst Trans-0.24% Short Ratio2.87 Perf Half Y-8.70%
Book/sh29.43 P/B5.14 EPS next Y15.10% ROA7.70% Target Price190.13 Perf Year18.31%
Cash/sh4.21 P/C35.92 EPS next 5Y10.36% ROE12.00% 52W Range126.21 - 206.04 Perf YTD16.70%
Dividend1.28 P/FCF60.55 EPS past 5Y-4.30% ROI6.10% 52W High-28.09% Beta1.01
Dividend %0.85% Quick Ratio3.50 Sales past 5Y15.70% Gross Margin66.80% 52W Low17.39% ATR5.23
Employees2000 Current Ratio4.60 Sales Q/Q12.70% Oper. Margin18.10% RSI (14)32.69 Volatility3.10% 3.03%
OptionableYes Debt/Eq0.51 EPS Q/Q6.60% Profit Margin19.30% Rel Volume0.50 Prev Close151.18
ShortableYes LT Debt/Eq0.49 EarningsJan 29 BMO Payout37.60% Avg Volume261.04K Price148.17
Recom2.10 SMA20-6.75% SMA50-12.86% SMA200-10.13% Volume91,264 Change-1.99%
Oct-31-18Downgrade Craig Hallum Buy → Hold
Oct-17-18Initiated Goldman Neutral $190
Jun-15-18Initiated Argus Buy $185
Jul-13-17Initiated Wells Fargo Market Perform
Feb-09-17Initiated Citigroup Buy $115
Jan-18-17Initiated Deutsche Bank Buy $115
Nov-10-16Resumed Leerink Partners Outperform $122
Jan-21-15Reiterated Robert W. Baird Outperform $102 → $104
Sep-20-13Upgrade Robert W. Baird Neutral → Outperform $76 → $90
Jun-08-12Initiated William Blair Mkt Perform
Feb-01-12Downgrade Robert W. Baird Outperform → Neutral $81 → $71
Feb-04-09Upgrade Robert W. Baird Neutral → Outperform $76 → $69
Feb-04-09Reiterated Leerink Swann Outperform $73.50 → $59.50
Oct-13-08Upgrade Leerink Swann Mkt Perform → Outperform
Apr-18-08Downgrade Robert W. Baird Outperform → Neutral $71
Sep-07-07Downgrade Leerink Swann Outperform → Mkt Perform
Jan-31-07Downgrade First Analysis Sec Overweight → Equal-Weight
Dec-06-18 12:14PM  Should You Think About Buying Bio-Techne Corporation (NASDAQ:TECH) Now? Simply Wall St.
Dec-04-18 09:15AM  Bio-Techne Releases GMP ROCK Inhibitor and CHIR 99021 for Stem Cell Therapy PR Newswire
Nov-20-18 09:15AM  Bio-Techne To Present At The Citi 2018 Global Healthcare Conference PR Newswire
06:31AM  New Strong Sell Stocks for November 20th Zacks
Nov-08-18 05:05PM  The List: Corporate board pay climbing? Not in Minnesota at least not this year American City Business Journals
Nov-03-18 06:16PM  Edited Transcript of TECH earnings conference call or presentation 30-Oct-18 1:00pm GMT Thomson Reuters StreetEvents
Nov-02-18 07:30AM  Report: Exploring Fundamental Drivers Behind Equity Lifestyle Properties, AvalonBay Communities, Kadant, Mastercard, Bio-Techne, and Erie Indemnity New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Oct-31-18 12:42PM  What Did Bio-Techne Corporations (NASDAQ:TECH) CEO Take Home Last Year? Simply Wall St.
Oct-30-18 02:54PM  Bio-Techne Corp (TECH) Q1 2019 Earnings Conference Call Transcript Motley Fool -6.26%
07:00AM  Bio-Techne Releases First Quarter Fiscal 2019 Results PR Newswire
07:00AM  Bio-Techne Declares Dividend PR Newswire
Oct-26-18 09:15AM  Bio-Techne To Present At The 2018 Stephens NY Investment Conference PR Newswire
Oct-18-18 11:01AM  Bio-Techne Partners Micropoint Bioscience, Expands in China Zacks
Oct-12-18 08:30AM  Bio-Techne Signs Strategic Cooperation Agreement with Micropoint Bioscience PR Newswire
Oct-11-18 09:00AM  Bio-Techne To Host Conference Call On October 30, 2018 To Announce First Quarter 2019 Financial Results PR Newswire
Oct-05-18 08:36AM  How Do Analysts See Bio-Techne Corporation (NASDAQ:TECH) Performing In The Next Couple Of Years? Simply Wall St.
Oct-02-18 09:15AM  Bio-Techne Scientist Presented with the CASSS CE Pharm Award PR Newswire
Oct-01-18 03:07PM  Edited Transcript of TECH earnings conference call or presentation 7-Aug-18 1:00pm GMT Thomson Reuters StreetEvents
Sep-27-18 09:15AM  Bio-Techne Announces Cell and Gene Therapy Initiative PR Newswire
Sep-19-18 09:15AM  Bio-Techne Supports International Antibody Validation Meetings PR Newswire
Sep-18-18 12:02PM  Bio-Techne Announces Publication of Data Demonstrating Additional Clinical Validation of its EPI Test in European Urology Journal PR Newswire
Sep-11-18 08:25AM  The Daily Biotech Pulse: Advaxis Posts Narrower Loss, Endocyte Announces $175M Offering, Leadership Transition At Insulet Benzinga
Sep-06-18 09:15AM  Bio-Techne Fills a Need for Simple Tools to Study Glycobiology PR Newswire
Sep-05-18 10:00AM  Bio-Techne To Present At The Morgan Stanley 16th Annual Global Healthcare Conference PR Newswire
Aug-31-18 10:40AM  Bio-Techne Corporation (NASDAQ:TECH): Set To Experience A Decrease In Earnings? Simply Wall St.
Aug-28-18 10:00AM  Bio-Techne To Present At The Baird 2018 Global Healthcare Conference PR Newswire
Aug-27-18 06:48PM  Bio-Techne Corp (TECH) Files 10-K for the Fiscal Year Ended on June 30, 2018 GuruFocus.com
Aug-08-18 09:00AM  Bio-Techne Introduces GMP Small Molecules for Stem Cell Therapy Development PR Newswire
Aug-07-18 07:00AM  Bio-Techne Releases Fourth Quarter Fiscal 2018 Results PR Newswire +6.69%
07:00AM  Bio-Techne Declares Dividend PR Newswire
07:00AM  Bio-Techne Corporation to Host Earnings Call ACCESSWIRE
Aug-02-18 09:00AM  Bio-Techne Announces 2018 Investor Day And Webcast PR Newswire
Aug-01-18 04:15PM  Bio-Techne Corporation Completed Its Acquisition of Exosome Diagnostics, Inc. PR Newswire
08:30AM  Market Trends Toward New Normal in Horizon Global, Bio-Techne, Adamis Pharmaceuticals, Kadant, Semgroup, and Provident Financial Services Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Jul-24-18 08:00AM  Bio-Techne Introduces New Member of the Simple Western Family, with IR/NIR Detection Capabilities PR Newswire
Jul-12-18 05:52PM  5 Tips for Making Money in Penny Stocks InvestorPlace
09:00AM  Bio-Techne To Host Conference Call On August 7, 2018 To Announce Fourth Quarter 2018 Financial Results PR Newswire
Jul-10-18 08:00AM  Bio-Techne Scales Antibody Validation Initiative Using CRISPR Gene Editing Technology Across a Broad Spectrum of Targets PR Newswire
Jun-26-18 10:00AM  Bio-Techne Expands RNAscope® Assay Services Portfolio to Shorten Development Times and Save Costs PR Newswire
Jun-25-18 04:09PM  Bio-Techne To Acquire Exosome Diagnostics, Inc. PR Newswire
Jun-22-18 07:47AM  Is Bio-Techne Corporation (NASDAQ:TECH) A Financially Strong Company? Simply Wall St.
Jun-07-18 08:00AM  Bio-Techne To Acquire Quad Technologies PR Newswire
Jun-04-18 10:00AM  Bio-Techne To Present At The William Blair 38th Annual Growth Stock Conference PR Newswire
May-24-18 10:00AM  Bio-Techne To Present At The Jefferies 2018 Healthcare Conference PR Newswire
May-16-18 08:00AM  Better Know Biotech: 2 Stocks You Ought to Know About Motley Fool
May-10-18 10:00AM  Bio-Techne To Present At The UBS Global Healthcare Conference PR Newswire
May-07-18 02:19PM  When Should You Buy Bio-Techne Corporation (NASDAQ:TECH)? Simply Wall St.
May-03-18 10:05PM  Edited Transcript of TECH earnings conference call or presentation 2-May-18 1:00pm GMT Thomson Reuters StreetEvents
May-02-18 10:18AM  Does Bio-Techne Corporations (NASDAQ:TECH) PE Ratio Warrant A Sell? Simply Wall St.
07:00AM  Bio-Techne Releases Third Quarter Fiscal 2018 Results PR Newswire
07:00AM  Bio-Techne Declares Dividend PR Newswire
May-01-18 10:00AM  Bio-Techne To Present At The Deutsche Bank 43rd Annual Health Care Conference PR Newswire
Apr-26-18 01:00PM  Bio-Techne Leads the Way in Scientific Support for Autophagy Research PR Newswire
Apr-24-18 04:15PM  Bio-Techne Announces New Leadership Appointment PR Newswire
Apr-18-18 07:55AM  New Research: Key Drivers of Growth for Bonanza Creek Energy, MarketAxess, LivaNova, Cintas, Bio-Techne, and Provident Financial Services Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Mar-29-18 07:45AM  New Research: Key Drivers of Growth for Bio-Techne, QTS Realty Trust, CYS Investments, Prologis, Gramercy Property Trust, and NanoString Technologies Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Mar-22-18 08:44AM  3 Reasons Momentum Stock Investors Will Love Bio-Techne (TECH) Zacks
Mar-21-18 01:00PM  Bio-Techne Expands RNAscope® ISH Automation - Facilitating Drug Discovery and Development PR Newswire
Mar-15-18 08:00AM  10 Growth Stocks for Long-Term Investors Investopedia
Mar-14-18 01:00PM  Bio-Techne Launches MimEX GI, an Accessible 3-D Cell Culturing Platform for the Gastrointestinal Tract PR Newswire
Feb-14-18 07:50AM  Blog Exposure - AVEO Announced Positive NICE Recommendation for FOTIVDA(R) as First Line Treatment for Advanced Renal Cell Carcinoma ACCESSWIRE
Feb-09-18 04:55AM  Edited Transcript of TECH earnings conference call or presentation 6-Feb-18 2:00pm GMT Thomson Reuters StreetEvents
Feb-07-18 09:00AM  Bio-Techne Named "Researchers' Choice" by CiteAb PR Newswire
Feb-06-18 11:39AM  What does Bio-Techne Corporations (NASDAQ:TECH) Balance Sheet Tell Us About Its Future? Simply Wall St.
09:25AM  Bio-Techne Declares Dividend PR Newswire
07:00AM  Bio-Techne Releases Second Quarter Fiscal 2018 Results PR Newswire
07:00AM  Bio-Techne Corporation to Host Earnings Call ACCESSWIRE
Feb-05-18 08:00AM  Bio-Techne To Present At The Leerink Partners 7th Annual Global Healthcare Conference PR Newswire
Jan-30-18 05:11PM  Bio-Techne's Ella Added to BioAgilytix Portfolio of Industry-Leading Immunoassay Platforms PR Newswire
Jan-26-18 07:40AM  Research Report Identifies Methode Electronics, Bio-Techne, VOXX International, American Tower Corporation (REIT), Medical Properties Trust, and HRG Group with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Jan-24-18 07:02AM  The Zacks Analyst Blog Highlights: Anthera Pharmaceuticals, Bio-Techne, Exelixis, Paratek and Bioverativ Zacks
Jan-18-18 07:30AM  Bio-Techne To Host Conference Call On February 6, 2018 To Announce Second Quarter 2018 Financial Results PR Newswire
Jan-15-18 09:00AM  Advanced Immunolabeling Reagents and Tools from Vector Laboratories Now from Bio-Techne PR Newswire
08:06AM  See what the IHS Markit Score report has to say about Bio-Techne Corp. Markit
Jan-02-18 05:01PM  Bio-Techne Acquires Atlanta Biologicals Inc. PR Newswire
Dec-28-17 08:00AM  Bio-Techne To Present At The 36th Annual J.P. Morgan Healthcare Conference PR Newswire
Dec-15-17 02:10PM  ETFs with exposure to Bio-Techne Corp. : December 15, 2017 Capital Cube
Nov-30-17 10:54AM  Edited Transcript of TECH earnings conference call or presentation 31-Oct-17 1:00pm GMT Thomson Reuters StreetEvents
Nov-28-17 08:30AM  Bio-Techne's RNAscope® Technology Enabling Robust Gene Expression and Biomarker Analysis Advances Wide-ranging Research with over 1000 Publications PR Newswire
Nov-27-17 03:54PM  ETFs with exposure to Bio-Techne Corp. : November 27, 2017 Capital Cube
Nov-20-17 07:30AM  Bio-Techne Offers Updated Novus Panel Builder, Facilitating Multicolor Flow Cytometry Panel Design PR Newswire
Nov-17-17 01:02PM  ETFs with exposure to Bio-Techne Corp. : November 17, 2017 Capital Cube
Nov-16-17 09:03AM  Bio-Techne Corp. :TECH-US: Earnings Analysis: Q1, 2018 By the Numbers : November 16, 2017 Capital Cube
Nov-14-17 10:00AM  Bio-Techne Awards 40,000 USD Research Grant to Innovative Cancer Researcher PR Newswire
Nov-08-17 07:40AM  Featured Company News - Japanese Patent Office Issued New Patent to Alexion Pharma's Soliris; Extending Patent Protection into 2027 ACCESSWIRE
Nov-07-17 09:00AM  Women In Bio Announces that Alpna Seth Joins Bio-Technes Board of Directors GlobeNewswire
Nov-01-17 03:00AM  Bio-Techne Shows Market Leadership With Jump To 81 RS Rating Investor's Business Daily
Oct-31-17 07:35AM  Bio-Techne Releases First Quarter Fiscal 2018 Results PR Newswire +5.99%
07:35AM  Bio-Techne Declares Dividend PR Newswire
07:30AM  Bio-Techne to Host Earnings Call ACCESSWIRE
Oct-30-17 12:18PM  ETFs with exposure to Bio-Techne Corp. : October 30, 2017 Capital Cube
08:48AM  Is a Surprise Coming for Bio-Techne (TECH) This Earnings Season? Zacks
Oct-27-17 09:00AM  Bio-Techne To Present At The Stephens Fall Investment Conference PR Newswire
Oct-26-17 05:00PM  Bio-Techne Adds Two New Directors to Its Board PR Newswire
Oct-16-17 08:06AM  See what the IHS Markit Score report has to say about Bio-Techne Corp. Markit
Oct-13-17 08:06AM  See what the IHS Markit Score report has to say about Bio-Techne Corp. Markit
Oct-11-17 07:30AM  Bio-Techne To Host Conference Call On October 31, 2017 To Announce First Quarter 2018 Financial Results PR Newswire
Oct-10-17 11:50AM  ETFs with exposure to Bio-Techne Corp. : October 10, 2017 Capital Cube
Oct-09-17 09:54AM  Bio-Techne Corp. :TECH-US: Earnings Analysis: Q4, 2017 By the Numbers : October 9, 2017 Capital Cube
Oct-05-17 07:30AM  Joint Consortia Framework Awards Contract to Bio-Techne as Supplier of Research Antibodies PR Newswire
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells biotechnology reagents, instruments, and clinical diagnostic controls worldwide. It operates in three segments: Biotechnology, Protein Platforms, and Diagnostics. The Biotechnology segment offers specialized proteins, such as cytokines and growth factors, immunoassays, antibodies, and related reagents to the biotechnology research community; and in situ hybridization, media, and other cell culture products and reagents. It also provides various products, which serves as predictive biomarkers and therapeutic targets for various human diseases and conditions, such as cancer, autoimmunity, diabetes, hypertension, obesity, inflammation, neurological disorders, and kidney failure. The Protein Platforms segment offers Biologics tools for researchers to interrogate protein purity and identify contaminants during the development and production of biologics; Western blot, an assay for protein analysis and identification; SimplePlex platform, an enzyme-linked immunosorbent assay for use in research and clinical diagnostics; and Single Cell Western platform to elucidate the properties of individual cells to understand cell behavior. The Diagnostics segment provides blood chemistry and gas quality controls, hematology instrument controls, diagnostic immunoassays, and other bulk and custom reagents for the in vitro diagnostic market. Bio-Techne Corporation has a strategic cooperation agreement with Micropoint Bioscience. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was founded in 1976 and is headquartered in Minneapolis, Minnesota.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BAUMGARTNER ROBERT VDirectorAug 24Option Exercise61.465,000307,30012,712Aug 28 05:30 PM
BAUMGARTNER ROBERT VDirectorAug 24Sale188.475,000942,3347,712Aug 28 05:30 PM
HIGGINS JOHN LDirectorAug 23Option Exercise61.0810,000610,80013,012Aug 27 04:12 PM
HIGGINS JOHN LDirectorAug 23Sale187.9210,0001,879,1733,012Aug 27 04:12 PM
Dinarello Charles ADirectorAug 08Option Exercise63.035,000315,15013,212Aug 10 04:18 PM
Dinarello Charles ADirectorAug 08Sale176.945,000884,6758,212Aug 10 04:18 PM
Eansor Norman DavidSVP - Novus BiologicalsAug 07Option Exercise0.001,19903,465Aug 09 06:29 PM
Furlow Brenda S.SVP - General CounselAug 07Option Exercise0.0095902,627Aug 09 06:26 PM
Hippel JamesChief Financial OfficerAug 07Option Exercise0.002,39805,477Aug 09 06:19 PM
Kummeth Charles R.Chief Executive OfficerAug 07Option Exercise0.0013,816090,288Aug 09 07:22 PM
Kummeth Charles R.Chief Executive OfficerJun 07Sale160.008,0001,280,00076,472Jun 08 04:21 PM
Eansor Norman DavidSVP - Novus BiologicalsMay 04Sale145.191,136164,9322,266May 11 04:16 PM
Dinarello Charles ADirectorFeb 13Option Exercise65.475,000327,35013,212Feb 15 04:02 PM
Dinarello Charles ADirectorFeb 13Sale136.065,000680,3038,212Feb 15 04:02 PM